The Exchange has sought clarification from Cipla Ltd on January 07, 2026, with reference to news appeared in https://www.moneycontrol.com/ dated January 07, 2026 quoting \Cipla shares slide 4.5% after USFDA flags compliance gaps at key Lanreotide supplier site\
The reply is awaited.